|
|
||||||||
Veterinary Biomedical Sciences and Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, Missouri 65211
| |
ABSTRACT |
|---|
|
|
|---|
Lipoprotein lipase (LPL) is a key enzyme for fatty acid
and lipoprotein metabolism in muscle. However, the effect of aging on
LPL regulation in skeletal muscle is unknown. We report the effect of
aging on LPL regulation in the soleus (red oxidative postural) muscle
and the tibialis anterior (white glycolytic non-weight-bearing) muscle
in 4- and 24-mo-old Fischer 344 rats and 18- and 31-mo-old Fischer
344 × Brown-Norway F1 (F-344 × BN F1) rats. Total and heparin-releasable LPL (HR-LPL) activities were decreased 38% (P
< 0.01) and 52% (P < 0.05), respectively, in the
soleus muscle of the older Fischer 344 rats. There was a 32% reduction
(P < 0.05) of total LPL protein mass in the soleus muscle
with aging. The results were confirmed in another strain. A decrease of
total LPL activity (
50%, P < 0.05) was also found in the
soleus muscle between 18- and 31-mo-old F-344 × BN F1 rats. LPL
mRNA concentration in the soleus muscle was not different between ages.
Total LPL protein mass was reduced by 46% (P < 0.05) in
the soleus muscle of the 31-mo-old F-344 × BN F1 rats. In the
tibialis anterior muscle, neither LPL activity nor mRNA concentration
was affected by age in either strain. In conclusion, LPL regulation in
a non-weight-bearing muscle was not affected by aging. However, there
was a pronounced reduction in LPL activity and LPL protein mass in
postural muscle with aging.
exercise; physical inactivity; very-low-density lipoprotein; lipid
| |
INTRODUCTION |
|---|
|
|
|---|
LIPOPROTEIN LIPASE (LPL) is a key enzyme in fatty acid and lipoprotein metabolism in muscle (4, 18). LPL hydrolyzes triglycerides (TGs) associated with very-low-density lipoprotein (VLDL) and chylomicrons in circulating blood. The liberated fatty acids are ultimately stored in adipose tissue or oxidized in skeletal muscle. LPL also enhances VLDL receptor-mediated uptake of lipoprotein and indirectly plays a vital role in maintaining high-density-lipoprotein cholesterol (HDL-C) concentration (4). Thus low LPL activity is often associated with high plasma TG concentration, delayed and elevated postprandial lipids, and low HDL-C concentration (30, 31).
Aging is associated with several unhealthy metabolic changes. In addition to the well-known risk for increased coronary heart disease in humans, several studies have shown that plasma TG concentration increases with aging (7, 33; see Ref. 20 for review). A delayed clearance for chylomicrons and VLDL was reported in elderly subjects after an oral fat load (3, 10). Hypothetically, these changes in TG concentration and the delayed clearance of postprandial VLDL or chylomicrons from plasma with aging may partly involve a decrease of LPL activity. A 56-60% reduction of the post-heparin plasma LPL activity has been reported in the elderly compared with younger adults (6, 27).
The LPL protein is synthesized by parenchymal cells (adipocytes, cardiomyocytes, and skeletal muscle fibers). The secreted protein is transported in a dimeric form to the intimal surface of the vascular endothelium, where it will hydrolyze TGs in TG-rich lipoproteins (4, 18).
Several studies of LPL regulation during aging have focused on adipose tissue and heart (7, 8, 35). The consensus of these studies was a loss of LPL activity in these tissues with aging (7, 8). Skeletal muscle is a particularly important site of LPL regulation, because this tissue is ~45% of the body mass. It is the largest LPL-producing tissue and has a very high rate of TG extraction from plasma (26) and fatty acid oxidation (25). However, we are unaware of any studies on the effect of aging on LPL regulation in skeletal muscle. An understanding of the aging effects on LPL regulation is greatly needed (19).
The purpose of this study is to determine the effects of old age on skeletal muscle LPL. The regulation of LPL in skeletal muscle of young animals has often been shown to be different between muscle types. LPL mRNA concentration, LPL protein mass, and LPL activity were low in white glycolytic muscles and high in red oxidative skeletal muscles (20, 34). Moreover, different responses of LPL activity and protein have been observed between white glycolytic and red oxidative muscles with exercise and physical inactivity (20, 29). For this reason, the soleus muscle (a red oxidative postural muscle with predominately type I fibers) and the tibialis anterior (TA) muscle (a predominantly white glycolytic non-weight-bearing muscle with a majority of type IIb and IId/x fibers) were used to determine the effect of aging on LPL activity. LPL mRNA concentration and LPL protein mass were measured to begin understanding the process involved in LPL regulation during aging. Because of the potential decrease of post-heparin plasma LPL activity with aging (6, 27) and the fact that skeletal muscle has been shown to be a major site of LPL production, we hypothesized that LPL activity would also decrease in skeletal muscle with aging. Because skeletal muscle LPL, especially postural muscle, has been shown to be sensitive to reduced activity of daily living (ambulatory activity) (20), which increases during aging, we hypothesized that the decrease of LPL activity in skeletal muscle with aging would be muscle type dependent. We first measured LPL activity in 4- and 24-mo-old Fischer 344 (F-344) rats. Because those results indicated a statistical difference between the young (4 mo) and old (24 mo) adults, we then sought to extend our study to the F-344 × Brown-Norway strain after the first generation of breeding (F-344 × BN F1 rats) using middle-aged (18 mo) and old (31 mo) adults.
| |
METHODS |
|---|
|
|
|---|
Animal procedures. Two strains of rats with different life spans that are commonly used in aging research were utilized. Specific pathogen-free F-344 rats at 4 and 24 mo of age (n = 5) were used in our first comparison to study the effect of aging on LPL regulation in skeletal muscle. The choice of the 24-mo-old F-344 rat as the oldest is appropriate, because the mean life span was found to be 24 mo (36). F-344 × BN F1 rats, with a mean life span of 31 mo, were used as well (15).
All rats were housed in a barrier facility with a 12:12-h light-dark cycle (lights on from 0700) and fed low-fat chow ad libitum. Animals were anesthetized by peritoneal injection of a mixture of ketamine (54 mg/ml), xylazine (2.2 mg/ml), and acepromazine (3.5 mg/ml) before tissue removal. The soleus and TA muscles were frozen immediately in liquid nitrogen and stored at
80°C.
Post-heparin eluate and tissue preparation.
Heparin-releasable LPL (HR-LPL) was obtained from a nonfrozen soleus
muscle mass (~50 mg) of each group of F-344 rats. This tissue was
weighed, minced to 10-mg pieces, and soaked immediately in PBS
containing 100 U/ml heparin (Sigma) for 30 min at 37°C. The eluate
was stored at
80°C for subsequent measurements of HR-LPL activity.
LPL enzyme activity. Heparinized supernatants and heparin eluates were assayed for LPL enzyme activity using a [3H]triolein substrate as described by Nilsson-Ehle and Schotz (28). LPL activity was measured by the rate of hydrolysis of [3H]triolein containing substrate emulsified with lecithin in the presence of heat-inactivated rat serum as the source of apolipoprotein C-II and fatty acid-free albumin (28). Assays were performed at 37°C for 60 min. LPL activity was expressed as nanomoles of fatty acid hydrolyzed per gram per minute. Each sample was measured in duplicate and at two different concentrations to ensure reproducibility and linearity. The assay was specific to LPL, because lipase activity was not detectable when the sample was incubated with monoclonal anti-rat LPL antibody before addition of substrate.
Determination of LPL protein mass.
LPL protein mass in the supernatants and post-heparin eluates was
determined using a chicken polyclonal anti-bovine LPL antibody (gift
from Dr. John Goers). Total protein (40-60 µg) from each sample
was separated on 7% sodium dodecyl sulfate-polyacrylamide gel and
transferred to a polyvinylidene difluoride nitrocellulose membrane
(Millipore). The membrane was blocked with 5% bovine serum albumin in
buffer (25 mM Tris · HCl and 0.15 M NaCl, pH 7.4) for 1 h
and then incubated with 1:5,000 polyclonal chicken anti-bovine LPL
antibodies for 2 h. After incubation, the membrane was washed with
a 0.05% Tween-Tris saline buffer and hybridized with 1:100,000
anti-chicken immunoglobulins conjugated with horseradish peroxidase for
1 h. The washes were repeated before the membrane was developed
with the enhanced chemiluminescence (ECL+) kit (Amersham Pharmacia
Biotech) and subjected to autoradiography. A 55-kDa band (Fig.
1) was detected as previously found in
adipose tissue by Goers et al. (17). Rat heart LPL protein
purified by affinity chromatography with a 1-ml heparin-Sepharose
column (Amersham Pharmacia Biotech) and a purified bovine LPL protein
(Sigma) were recognized at the same level of migration of LPL protein
present in our muscle homogenate (Fig. 1, A and
B). Membranes that were hybridized only with the secondary
antibody did not reveal a nonspecific band near the LPL size (Fig. 1,
B and C). The integrated optical density (IOD) of
each band was quantified using a Personal Densitometer SI (Molecular
Dynamics, Amersham Pharmacia Biotech) and ImageQuant (Molecular
Dynamics).
|
Determination of LPL mRNA concentration. Northern blot analysis was performed with total RNA extracted from powdered muscle by the procedure described previously (20). Total RNA was isolated with the method developed by Chomczynski and Sacchi (12). Samples of total RNA were fractionated on a formaldehyde-agarose gel, transferred to nylon membranes, and hybridized for LPL transcripts with a random-primed 32P-labeled rat LPL cDNA probe. The radiolabeled membrane was subjected to autoradiography with intensifying screens, and the IOD of each band was quantified. LPL mRNA concentration was expressed as LPL IOD per microgram of total RNA. The same membrane was subsequently hybridized with 32P-labeled rat glyceraldehyde 3-phosphate dehydrogenase (GAPDH) cDNA probe. Values for LPL mRNA concentration were also normalized to GAPDH mRNA. There was no age effect on GAPDH IOD per microgram of total RNA. Dose-response analysis with increasing amounts of RNA was performed for each muscle group to verify that the IOD reflected quantitative changes in LPL mRNA concentration. Ethidium bromide staining was also performed to confirm the absence of RNA degradation and the equivalence of RNA loading.
Statistics. One-way analysis of variance was used to test the significance of aging on LPL activity, protein mass, and mRNA in skeletal muscles. When the analysis of variance was significant, a protected least significant difference Fisher's test was used for comparisons between ages. Results were considered significant at P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Effect of aging on total and HR-LPL activity in the soleus and TA
muscles.
HR-LPL was 52% (P < 0.05) less in the soleus muscle of
24-mo-old than 4-mo-old rats (Fig.
2A). Total LPL activity was
also decreased 38% (P < 0.01) in the soleus muscle of
24-mo-old rats (Fig. 2B). Total LPL activity was fivefold
greater (P < 0.01) in the soleus muscle than in the TA
muscle of 4-mo-old F-344 rats (Fig. 2, B and C).
However, total LPL activity in the TA muscle was not different between
ages (Fig. 2C). The effect of aging on skeletal muscle LPL
activity was confirmed in F-344 × BN F1 rats. Total LPL activity
was decreased by 50% (P = 0.02) in the soleus muscle
between 18 and 31 mo of age (Fig. 2D). Total LPL activity
was fivefold greater in the soleus than in the TA muscle of 18-mo-old
F-344 × BN F1 rats (Fig. 2, D and E). As
with the F-344 strain, total LPL activity was not age dependent in the TA muscle of the F-344 × BN F1 rats (Fig. 2E).
|
Effect of aging on LPL mRNA concentration in the soleus and TA
muscles.
LPL mRNA concentration was measured in the soleus and TA muscles from
18- and 31-mo-old F-344 × BN F1 rats by Northern blot analysis
(Fig. 3). LPL mRNA concentration
(IOD/µg of total RNA or LPL/GAPDH) was not significantly different
between ages in either muscle type (Fig. 3).
|
Effect of aging on total LPL protein mass in the soleus muscles.
Total LPL protein mass was determined in the soleus muscle from 18- and
31-mo-old F-344 × BN F1 rats and 4- and 24-mo-old F-344 rats. In
parallel with the decrease of total LPL activity in the soleus muscle
between 18- and 31-mo-old F-344 × BN F1 rats, total LPL protein
mass was decreased significantly by 46% (P < 0.05)
with aging (Fig. 4A). Total
LPL protein mass was also reduced significantly by 32%
(P < 0.05) in the soleus muscle between 4- and
24-mo-old F-344 rats (Fig. 4B).
|
| |
DISCUSSION |
|---|
|
|
|---|
This study clearly demonstrates a large decrease in HR-LPL and total LPL activities in a red oxidative postural muscle (soleus) with aging in two different strains of rats. This decrease of LPL activity in skeletal muscle could potentially alter the use of TGs by muscle or contribute to other changes in lipid metabolism. We found that total LPL activity was 38% lower in the soleus muscle of F-344 rats at 24 mo of age than at 4 mo of age (Fig. 2B). Total LPL activity was also decreased by 50% in the soleus muscle between 18 and 31 mo of age in F-344 × BN F1 rats (Fig. 2D). A 52% decrease of HR-LPL activity was found in the soleus muscle between 4- and 24-mo-old F-344 rats (Fig. 2A). These results indicate a loss of LPL activity within muscle fibers and in the extracellular fraction associated with endothelial cells.
High concentration of TG in plasma is associated with an increased risk for coronary heart disease (14, 16). Overexpression of LPL in skeletal muscle has been shown to decrease plasma TG concentration, increase HDL-C level, and prevent diet-induced hyperlipidemia and obesity (23, 32). A 50% increase in the plasma TG concentration occurs between 6 and 27 mo of age in F-344 rats (2). This increase was associated previously with a low total LPL activity in adipose tissue in old rats (2). Now, we have also shown that the total and HR-LPL activity (present in the capillaries) within skeletal muscle is also significantly reduced during aging.
The LPL changes during aging were muscle type dependent. Total LPL activity and mRNA in the TA muscle, a white glycolytic non-weight-bearing muscle, was not affected by aging (Figs. 2 and 3). We reported in our study that total LPL activity was fivefold greater in the soleus than in the TA muscle for 18-mo-old F-344 × BN F1 rats and 4-mo-old F-344 rats. This difference of LPL activity between muscle types was attenuated with aging (Fig. 2). A muscle-type-dependent LPL regulation has been observed in several different muscles during exercise studies (20, 29). LPL activity was lower in white glycolytic than in red oxidative muscles of sedentary young adult rats (20, 29). Intense exercise training increased LPL activity in white glycolytic hindlimb muscles but did not induce an increase in the soleus muscle, in which LPL activity was already high in controls (1, 20).
However, the decrease of LPL activity and protein mass is unlikely to be caused by the change of fiber type in the soleus muscle during aging. Chen and Alway (11) reported a reduction in type IIa and IId/x fibers and a corresponding increase in the percentage of type I fibers in soleus muscles of aged F-344 × BN F1 rats. Thus the fiber type changes during aging are in the opposite direction to explain the observed decreases in LPL activity and protein in the soleus muscle.
The decrease of spontaneous cage activity associated with aging could
potentially be responsible for the decrease in LPL activity with aging.
Aging is associated with a reduction of physical activity in most
species. Contractile activity is important to maintain LPL activity in
muscle (20). LPL activity and protein fell significantly in the soleus muscle after 7 days of hindlimb immobilization compared with normal ambulatory activity (20), but it was unchanged
in the TA muscle (unpublished observation; LPL activity: 98.7 ± 6.6 and 98.1 ± 7.8 nmol fatty
acid · g
1 · min
1 in control
and immobilized animals, respectively; LPL protein: 0.47 ± 0.03 and 0.45 ± 0.03 units/mg in control and immobilized animals,
respectively). Thus, similar to aging, the effects of physical
inactivity on muscle regulation are also muscle type dependent and
predominantly in postural muscle. However, a caveat to this comparison
is that LPL mRNA concentration in the soleus muscle of young rats
decreased after complete immobilization (20).
Cartee (9) described other effects of aging on skeletal muscle lipid and carbohydrate metabolism and the impact of physical inactivity. Muscle capillarization and mitochondrial enzyme concentrations are reduced during aging in sedentary humans (13). In old rats, muscle capillarity is unchanged, whereas blood flow during contractile activity and muscle oxidative capacity are reduced. The effect of aging on oxidative capacity of muscle can be reversed by physical activity (24). After training, old rats and elderly humans attain a restoration of muscle oxidative capacity quite similar to that of their identically trained younger counterparts (9). More studies are needed to determine the impact of exercise on lipid metabolism in the elderly, but existing studies indicate that adaptation is preserved in the elderly (for review see Ref. 19).
This is the first study that has reported the effect of aging on LPL activity in a hindlimb skeletal muscle. Bergö et al. (5) found that soleus LPL activity was more responsive to feeding in 1-mo-old than in 9-mo-old Sprague-Dawley rats. Carlile and Lacko (7) reported an increase of LPL activity in epididymal adipose tissue between 2- and 24-mo-old Sprague-Dawley rats and a decrease of LPL activity in epididymal adipose tissue between 2- and 24-mo-old F-344 rats. A decrease of LPL activity has been found in the heart of F-344 rats with aging (7, 8) but not in Sprague-Dawley rats (7). Thus the effect of aging on LPL activity in adipose tissue and heart seems to be dependent on the rat strain. In contrast, we found a similar effect of aging on LPL activity and protein mass in the soleus and TA muscles of two different strains.
The underlying mechanism for the decrease in LPL activity in the soleus muscle with aging was apparently posttranscriptional. LPL mRNA concentration was not reduced in old rats (Fig. 3). Total LPL protein mass was decreased by 46% in the soleus muscle between 18- and 31-mo-old F-344 × BN F1 rats (Fig. 4A) and reduced by 32% between 4- and 24-mo-old F-344 rats (Fig. 4B). In contrast, Hotta et al. (22) found a decrease of LPL mRNA level in adipose tissue between young (7 yr) and old (30 yr) rhesus monkeys, suggesting that the mechanism of LPL regulation in adipose tissue with aging involves a pretranslational process. It is not uncommon that adipose tissue and skeletal muscle regulate LPL activity by different mechanisms.
In conclusion, we showed for the first time that total and HR-LPL activities and LPL protein mass are decreased in a red oxidative postural skeletal muscle with aging. These decreases were independent of a decrease of mRNA concentration, suggesting a posttranscriptional process with aging. However, this aging effect is dependent on the type of leg muscle, because it did not occur in a white glycolytic non-weight-bearing muscle. The mechanism of altered LPL regulation with aging is possibly different between the soleus muscle and the adipose tissue, because previous studies reported reduced LPL mRNA concentration in adipose tissue. The specific loss of LPL activity in an oxidative (soleus) muscle and not in the more glycolytic (TA) muscle during aging may be because contractile activity is a major determinant of muscle LPL activity (20) and because the low-intensity ambulatory activities that are reduced during aging would involve the soleus more than the TA muscle (21).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Warren McClure for technical assistance, John Goers for LPL antibody, and Drs. Frank Booth and Donna Korzick for sharing some of the animals.
| |
FOOTNOTES |
|---|
This work was partially supported by National Heart, Lung, and Blood Institute Grant HL-57367 (to M. T. Hamilton) and the Life Science Mission Enhancement Postdoctoral Fellowship from the University of Missouri-Columbia (to L. Bey).
Address for reprint requests and other correspondence: M. T. Hamilton, Veterinary Medicine Bldg., 1600 E. Rollins, University of Missouri-Columbia, Columbia, MO 65211 (E-mail: hamiltonm{at}missouri.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 10 January 2001; accepted in final form 14 March 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bagby, GJ,
Johnson JL,
Bennett BW,
and
Shepherd RE.
Muscle lipoprotein lipase activity in voluntary exercising rats.
J Appl Physiol
60:
1623-1627,
1986
2.
Barakat, H,
Dohm GL,
Shukla N,
Marks HL,
Kern M,
Carpenter JW,
and
Mazzeo RS.
Influence of age and exercise training on lipid metabolism in Fischer-344 rats.
J Appl Physiol
67:
1638-1642,
1989
3.
Becker, GH,
Meyer J,
and
Necheles H.
Fat absorption and atherosclerosis.
Science
100:
529-530,
1950.
4.
Beisiegel, U,
and
Heeren J.
Lipoprotein lipase (EC 31134) targeting of lipoproteins to receptors.
Proc Nutr Soc
56:
731-737,
1997[Web of Science][Medline].
5.
Bergö, M,
Olivecrona G,
and
Olivecrona T.
Regulation of adipose tissue lipoprotein lipase in young and old rats.
Int J Obes Relat Metab Disord
21:
980-986,
1997[Web of Science][Medline].
6.
Brodows, RG,
and
Campbell RG.
Effect of age on post-heparin lipase.
N Engl J Med
9:
969-970,
1972.
7.
Carlile, SI,
and
Lacko AG.
Strain differences in the age-related changes of rat lipoprotein lipase metabolism.
Comp Biochem Physiol
70B:
753-758,
1981.
8.
Carlile, SI,
and
Lacko AG.
Age-related changes in plasma lipid levels and tissue lipoprotein lipase activities of Fischer-344 rats.
Arch Gerontol Geriatr
4:
133-140,
1985[Web of Science][Medline].
9.
Cartee, GD.
Aging skeletal muscle: response to exercise.
Exerc Sport Sci Rev
22:
91-120,
1994[Medline].
10.
Cassader, M,
Gambino R,
Ruiu G,
Marena S,
Badoni P,
and
Pagano G.
Postprandial triglyceride-rich lipoprotein changes in elderly and young subjects.
Aging (Milano)
8:
421-428,
1996[Medline].
11.
Chen, KD,
and
Alway S.
A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats.
J Appl Physiol
89:
606-612,
2000
12.
Chomczynski, P,
and
Sacchi N.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem
162:
156-159,
1987[Web of Science][Medline].
13.
Coggan, AR,
Spina RJ,
King DS,
Rogers MA,
Brown M,
Nemeth PM,
and
Holloszy JO.
Histochemical and enzymatic comparison of the gastrocnemius muscle of young and elderly men and women.
J Gerontol B Psychol Sci Soc Sci
47:
B71-B76,
1992.
14.
Cullen, P.
Evidence that triglycerides are an independent coronary heart disease risk factor.
Am J Cardiol
86:
943-949,
2000[Web of Science][Medline].
15.
Fernandes, G,
Venkatraman JT,
Turturro A,
Attwood VG,
and
Hart RW.
Effect of food restriction on life span and immune functions in long-lived Fischer-344 × Brown-Norway F1 rats.
J Clin Immunol
17:
85-95,
1997[Web of Science][Medline].
16.
Gaziano, JM.
Triglycerides and coronary risk.
Curr Cardiol Rep
2:
125-130,
1999.
17.
Goers, JW,
Pedersen ME,
Kern PA,
Ong J,
and
Schotz MC.
An enzyme-linked immunoassay for lipoprotein lipase.
Anal Biochem
166:
27-35,
1987[Web of Science][Medline].
18.
Goldberg, IJ.
Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis.
J Lipid Res
37:
693-707,
1996[Abstract].
19.
Hamilton MT, Areiqat E, Hamilton DG, and Bey L. Plasma
triglyceride metabolism in humans and rats during aging and physical
inactivity. JAPA. In press.
20.
Hamilton, MT,
Etienne J,
McClure WC,
Pavey BS,
and
Holloway AK.
Role of local contractile activity and muscle fiber type on LPL regulation during exercise.
Am J Physiol Endocrinol Metab
275:
E1016-E1022,
1998
21.
Hennig, R,
and
Lomo T.
Firing patterns of motor units in normal rats.
Nature
314:
164-166,
1985[Medline].
22.
Hotta, K,
Bodkin NL,
Gustafson TA,
Yoshioka S,
Ortmeyer HK,
and
Hansen BC.
Age-related adipose tissue mRNA expression of ADD1/SREBP1, PPAR
, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys.
J Gerontol A Biol Sci Med Sci
54:
B183-B188,
1999[Abstract].
23.
Jensen, DR,
Schlaepfer IR,
Morin CL,
Pennington DS,
Marcell T,
Ammon SM,
Gutierrez-Hartmann A,
and
Eckel RH.
Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase.
Am J Physiol Regulatory Integrative Comp Physiol
273:
R683-R689,
1997
24.
Kent-Braun, JA,
and
Ng AV.
Skeletal muscle oxidative capacity in young and older women and men.
J Appl Physiol
89:
1072-1078,
2000
25.
Kiens, B,
and
Lithell H.
Lipoprotein metabolism influenced by training-induced changes in human skeletal muscle.
J Clin Invest
83:
558-564,
1989.
26.
Mackie, BG,
Dudley GA,
Kaciuba-Uscilko H,
and
Terjung RL.
Uptake of chylomicron triglycerides by contracting skeletal muscle in rats.
J Appl Physiol
49:
851-855,
1980
27.
Nikkilä, EA,
and
Niemi T.
Effect of age on the lipemia clearing activity of serum after administration of heparin to human subjects.
J Gerontol
12:
44-47,
1957[Medline].
28.
Nilsson-Ehle, P,
and
Schotz MC.
A stable radioactive substrate emulsion for assay of lipoprotein lipase.
J Lipid Res
17:
536-541,
1976[Abstract].
29.
Ong, JM,
Simsolo RB,
Saghizadeh M,
Goers JW,
and
Kern PA.
Effects of exercise training and feeding on lipoprotein lipase gene expression in adipose tissue, heart, and skeletal muscle of the rat.
Metabolism
44:
1596-1605,
1995[Web of Science][Medline].
30.
Reymer, PW,
Gagne E,
Groenemeyer BE,
Zhang H,
Forsyth I,
Jansen H,
Seidell JC,
Kromhout D,
Lie KE,
Kastelein J,
and
Hayden MR.
A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis.
Nat Genet
10:
28-43,
1995[Web of Science][Medline].
31.
Shimada, M,
Ishibashi S,
Takanari G,
Kawamura M,
Yamamoto K,
Inaba T,
Harada K,
Ohsuga J,
Perrey S,
Yazaki Y,
and
Nobuhiro Y.
Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia.
Arterioscler Thromb
15:
1688-1694,
1995
32.
Shimada, M,
Shimano H,
Gotoda T,
Yamamoto K,
Kawamura M,
Inaba T,
Yazaki Y,
and
Yamada N.
Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia.
J Biol Chem
268:
17924-17929,
1993
33.
Story, JA,
Gomolinsky E,
Czarnecki SK,
Tepper SA,
and
Kritchesky D.
Age-strain interrelations in lipid metabolism of rats.
Lipids
16:
87-92,
1981[Medline].
34.
Tikkanen, HO,
Naveri H,
and
Harkonen M.
Skeletal muscle fiber distribution influences serum high-density lipoprotein cholesterol level.
Atherosclerosis
120:
1-5,
1996[Medline].
35.
Ursini, F,
Vugman M,
Fernandes LC,
Curi C,
and
Curi R.
Metabolic changes of several adipose depots as caused by aging.
Physiol Behav
50:
317-321,
1991[Medline].
36.
Yu, BP,
Masoro EJ,
Murata I,
Bertrand HA,
and
Lynd FT.
Lifespan of SPF Fischer 344 male rats fed ad libitum or restricted diets: longevity, growth, lean body mass and disease.
J Gerontol
27:
130-141,
1982.
This article has been cited by other articles:
![]() |
M. T. Hamilton, D. G. Hamilton, and T. W. Zderic Role of Low Energy Expenditure and Sitting in Obesity, Metabolic Syndrome, Type 2 Diabetes, and Cardiovascular Disease Diabetes, November 1, 2007; 56(11): 2655 - 2667. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Stump, M. T. Hamilton, and J. R. Sowers Effect of Antihypertensive Agents on the Development of Type 2 Diabetes Mellitus Mayo Clin. Proc., June 1, 2006; 81(6): 796 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Zderic and M. T. Hamilton Physical inactivity amplifies the sensitivity of skeletal muscle to the lipid-induced downregulation of lipoprotein lipase activity J Appl Physiol, January 1, 2006; 100(1): 249 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bey and M. T Hamilton Suppression of skeletal muscle lipoprotein lipase activity during physical inactivity: a molecular reason to maintain daily low-intensity activity J. Physiol., September 1, 2003; 551(2): 673 - 682. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |